Document Detail


Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial.
MedLine Citation:
PMID:  11350109     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Aims The purpose of this study was to validate ST segment resolution as a non-invasive marker for patency of the infarct-related artery 90 min after the start of streptokinase therapy in patients with acute myocardial infarction. Methods and Results In the HIT-4 angiographic substudy, 447 patients with acute myocardial infarction </=6 h received 1.5 million IU streptokinase. Angiograms of the infarct vessel were obtained after 90 min and 12-lead ECGs at baseline and after 90 min. The best cut-off points for a correct prediction of 90 min infarct vessel patency (TIMI 2/3 flow) and complete patency (TIMI 3) were 30% ST resolution and 40% ST resolution, respectively (specificity 68% and 69%, sensitivity 76% and 75%). Prediction of infarct vessel patency by ST resolution in steps of 10% displayed a gradual increase in patency rates. Patients with > or =70% ST resolution (n=70) had a 92% probability of TIMI 2/3 flow, while <30% ST resolution (n=172) was associated with the absence of TIMI 3 flow in 84% of patients. Conclusions Despite fairly good sensitivities and specificities the prediction of infarct vessel patency by ST resolution in the individual patient is limited. However, patients with > or =70% ST resolution are likely to have a patent infarct artery and <30% ST resolution predicts epicardial vessel occlusion or, since persistent ST elevation reflects the existing ischaemic myocardial injury, absence of myocardial perfusion.
Authors:
U Zeymer; R Schröder; U Tebbe; G P Molhoek; K Wegscheider; K L Neuhaus
Related Documents :
3055909 - Physiologic bases for anterior st segment depression in patients with acute inferior wa...
7884369 - Basic components and patterns of acute ischemia recovery assessed from continuous st mo...
6498029 - Implications of precordial st segment depression during acute inferior myocardial infar...
11804979 - Timi myocardial perfusion grade and st segment resolution: association with infarct siz...
12915929 - Distinction between myocardial ischemia and postural changes in continuous ecg monitori...
12394949 - Prognostic significance of admission cardiac troponin t in patients treated successfull...
3025459 - Interaction of ischemia and reperfusion with subtoxic concentrations of acetylstrophant...
18309549 - Silent bony calcification of coronaries in an adolescent--an unusual case.
8144769 - Percutaneous transluminal angioplasty of saphenous vein grafts for medically refractory...
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European heart journal     Volume:  22     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  2001 May 
Date Detail:
Created Date:  2001-05-14     Completed Date:  2001-09-06     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  England    
Other Details:
Languages:  eng     Pagination:  769-75     Citation Subset:  IM    
Copyright Information:
Copyright 2001 The European Society of Cardiology.
Affiliation:
Medizinische Klinik II, Klinikum Kassel, Mönchebergstrasse 41-43, D-34125 Kassel, Federal Republic of Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Double-Blind Method
Electrocardiography*
Female
Fibrinolytic Agents / therapeutic use
Heparin / therapeutic use
Hirudin Therapy
Humans
Male
Middle Aged
Myocardial Infarction / drug therapy*,  physiopathology
Myocardial Reperfusion*
Predictive Value of Tests
Prospective Studies
Statistics as Topic
Streptokinase / therapeutic use
Thrombolytic Therapy*
Vascular Patency*
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; 9005-49-6/Heparin; EC 3.4.-/Streptokinase
Comments/Corrections
Comment In:
Eur Heart J. 2001 May;22(9):722-4   [PMID:  11350102 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Gender differences in recurrent coronary events; the FINMONICA MI register.
Next Document:  In-hospital mortality of habitual cigarette smokers after acute myocardial infarction; the "smoker's...